MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY:DVA)

197.16 +2.55 (+1.31%)
Streaming Delayed Price Updated: 11:17 AM EDT, May 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DaVita HealthCare Partner

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
News headline image
3 No-Brainer Warren Buffett Stocks to Buy Right Now ↗
The Oracle of Omaha's approach to picking stocks still works as well as it ever has. 
Via The Motley Fool
Topics Credit Cards
News headline image
Why DaVita (DVA) Stock Is Nosediving
Shares of dialysis provider DaVita Inc. (NYSE:DVA) fell 8.5% in the afternoon session after the company reported a decline in patient treatment volumes and lowered its full-year forecast for the key... 
Via StockStory
Topics Artificial Intelligence
News headline image
Which S&P500 stocks are moving on Wednesday? ↗
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
News headline image
Earnings Scheduled For August 5, 2025 ↗
 
Via Benzinga
News headline image
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Curious about the market action on Wednesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
News headline image
These S&P500 stocks that are showing activity before the opening bell on Wednesday. ↗
Pre-market stock analysis of S&P500 stocks on 2025-08-06: top gainers and losers in today's session. 
Via Chartmill
News headline image
DaVita’s (NYSE:DVA) Q2 Sales Beat Estimates
Dialysis provider DaVita Inc. (NYSE:DVA) announced better-than-expected revenue in Q2 CY2025, with sales up 6.1% year on year to $3.38 billion. Its non-GAAP profit of $2.95 per share was 7.3% above... 
Via StockStory
Topics Earnings
News headline image
DaVita Inc (NYSE:DVA) Reports Mixed Q2 2025 Earnings with EPS Beat and Slight Revenue Miss ↗
DaVita Inc (NYSE:DVA) reported mixed Q2 2025 earnings, with revenue slightly missing estimates at $3.38B but EPS beating at $2.95. Stock rose modestly post-release. 
Via Chartmill
News headline image
Warren Buffett Just Bought Even More of This Dirt-Cheap Stock ↗
Berkshire Hathaway now owns 37% of this company. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Warren Buffett's Berkshire Hathaway Offloads $230 Million In DaVita Stock Ahead Of Q2 Earnings ↗
Berkshire Hathaway sold 1.64 million shares of DaVita Inc. for $230 million just before DaVita's Q2 earnings. 
Via Benzinga
News headline image
Warren Buffett's Berkshire Hathaway Offloads $230M Of This Dialysis Service Provider Ahead Of Its Q2 Earnings ↗
Analysts expect a strong Q2 for DaVita, with projected year-over-year growth in revenue, EBITDA, and earnings. 
Via Stocktwits
News headline image
DaVita (DVA) To Report Earnings Tomorrow: Here Is What To Expect
Dialysis provider DaVita Inc. (NYSE:DVA) will be reporting results this Tuesday after market hours. Here’s what to look for. 
Via StockStory
Topics World Trade
News headline image
3 Healthcare Stocks We Approach with Caution
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
News headline image
Wednesday's session: top gainers and losers in the S&P500 index ↗
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
News headline image
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
News headline image
CorMedix Spikes To Four-Year High On A Surprise Deal For Its Leading Drug ↗
CorMedix shares bounded to a four-year high Monday after the biotech company inked an expanded deal for its leading drug. 
Via Investor's Business Daily
News headline image
Winners And Losers Of Q1: DaVita (NYSE:DVA) Vs The Rest Of The Outpatient & Specialty Care Stocks
Let’s dig into the relative performance of DaVita (NYSE:DVA) and its peers as we unravel the now-completed Q1 outpatient & specialty care earnings season. 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Profitable Stock Worth Your Attention and 2 to Approach with Caution
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
News headline image
DVA Q1 Earnings Call: Cyber Incident, Volume Decline, and Policy Updates Shape Outlook
Dialysis provider DaVita Inc. (NYSE:DVA) fell short of the market’s revenue expectations in Q1 CY2025 as sales rose 5% year on year to $3.22 billion. Its non-GAAP EPS of $2 per share was 1% below... 
Via StockStory
News headline image
3 Value Stocks with Questionable Fundamentals
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
Topics Economy
News headline image
3 S&P 500 Stocks Walking a Fine Line
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Economy Stocks
News headline image
Buffett Bought More of This High-Yield Dividend Stock in Q1. Should You Buy It, Too? ↗
Via The Motley Fool
News headline image
Made in the USA: Warren Buffett Sells Out of 1 International Stock and Doubles His Stake in 2 U.S. Companies ↗
Via The Motley Fool
News headline image
Buffett's Latest Portfolio Moves, and Another Secret Stock
Buffett's latest 13F shows no new positions in publicly traded companies, but includes a confidential mystery stake, sparking significant speculation. 
Via MarketBeat
Topics Regulatory Compliance
News headline image
Gapping S&P500 stocks in Monday's session ↗
Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Warren Buffett Just Sold These 8 Stocks, One of Which Remains a Phenomenal Bargain (and a Top Holding of Mine) ↗
The Oracle of Omaha has been a big-time seller of stocks for 10 consecutive quarters -- but there's one sale he may regret. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Warren Buffett Ditches Bitcoin-Linked Nu Holdings, Adds To Constellation Brands, Domino's Pizza, Pool Corp Stakes ↗
As legendary investor Warren Buffett prepares to step down as CEO of Berkshire Hathaway Inc. 
Via Benzinga
News headline image
These S&P500 stocks have an unusual volume in today's session ↗
In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Tuesday's session. 
Via Chartmill
News headline image
These S&P500 stocks are gapping in today's session ↗
Stay tuned for the market movements in the S&P500 index on Tuesday. Check out the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
News headline image
DaVita (NYSE:DVA) Beats Q1 Sales Targets
Dialysis provider DaVita Inc. (NYSE:DVA) announced better-than-expected revenue in Q1 CY2025, with sales up 5% year on year to $3.22 billion. Its non-GAAP profit of $2 per share was 1% below analysts’... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story